147.72
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$146.22
Offen:
$147.37
24-Stunden-Volumen:
1.37M
Relative Volume:
0.86
Marktkapitalisierung:
$21.66B
Einnahmen:
$9.61B
Nettoeinkommen (Verlust:
$1.53B
KGV:
14.13
EPS:
10.453
Netto-Cashflow:
$1.85B
1W Leistung:
+2.83%
1M Leistung:
+5.02%
6M Leistung:
+24.25%
1J Leistung:
-20.54%
Biogen Inc Stock (BIIB) Company Profile
Firmenname
Biogen Inc
Sektor
Telefon
(781) 464-2000
Adresse
225 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie BIIB mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BIIB
Biogen Inc
|
147.72 | 21.44B | 9.61B | 1.53B | 1.85B | 10.45 |
![]()
LLY
Lilly Eli Co
|
812.43 | 716.78B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
192.94 | 462.11B | 92.15B | 25.12B | 18.18B | 10.36 |
![]()
ABBV
Abbvie Inc
|
228.68 | 408.76B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
131.43 | 254.25B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
87.61 | 218.86B | 63.43B | 16.42B | 14.72B | 6.4861 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-25 | Eingeleitet | Jefferies | Buy |
2025-07-21 | Fortgesetzt | Truist | Hold |
2025-04-28 | Herabstufung | HSBC Securities | Buy → Hold |
2025-04-04 | Herabstufung | Argus | Buy → Hold |
2025-02-11 | Eingeleitet | Bernstein | Mkt Perform |
2025-01-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2024-12-16 | Herabstufung | Stifel | Buy → Hold |
2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
2024-11-18 | Herabstufung | Needham | Buy → Hold |
2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
2024-11-14 | Eingeleitet | Citigroup | Neutral |
2024-10-31 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-10-10 | Fortgesetzt | Raymond James | Mkt Perform |
2024-02-14 | Bestätigt | Needham | Buy |
2024-02-14 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2024-01-24 | Herabstufung | UBS | Buy → Neutral |
2023-12-20 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2023-12-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-09-06 | Eingeleitet | HSBC Securities | Buy |
2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
2023-07-24 | Bestätigt | UBS | Buy |
2023-05-01 | Hochstufung | Guggenheim | Neutral → Buy |
2023-04-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-10-26 | Hochstufung | Goldman | Neutral → Buy |
2022-10-13 | Hochstufung | Stifel | Hold → Buy |
2022-10-07 | Hochstufung | Argus | Hold → Buy |
2022-09-28 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
2022-09-28 | Hochstufung | Mizuho | Neutral → Buy |
2022-09-28 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2022-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-03-08 | Herabstufung | Stifel | Buy → Hold |
2022-03-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2022-02-04 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2022-02-04 | Bestätigt | Barclays | Equal Weight |
2022-02-04 | Bestätigt | BofA Securities | Neutral |
2022-02-04 | Bestätigt | Cowen | Outperform |
2022-02-04 | Bestätigt | Morgan Stanley | Overweight |
2022-02-04 | Bestätigt | Needham | Buy |
2022-02-04 | Bestätigt | Oppenheimer | Outperform |
2022-02-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
2022-02-04 | Bestätigt | Robert W. Baird | Neutral |
2022-02-04 | Bestätigt | Wedbush | Neutral |
2022-02-04 | Bestätigt | Wells Fargo | Equal Weight |
2022-02-04 | Bestätigt | Wolfe Research | Peer Perform |
2022-01-13 | Herabstufung | Guggenheim | Buy → Neutral |
2022-01-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-12-10 | Fortgesetzt | Raymond James | Mkt Perform |
2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
2021-12-06 | Eingeleitet | Goldman | Neutral |
2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
2021-09-23 | Eingeleitet | Needham | Buy |
2021-06-18 | Hochstufung | Piper Sandler | Neutral → Overweight |
2021-06-14 | Bestätigt | Truist | Buy |
2021-06-11 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2021-06-10 | Hochstufung | UBS | Neutral → Buy |
2021-06-08 | Hochstufung | Atlantic Equities | Underweight → Neutral |
2021-06-08 | Bestätigt | Barclays | Equal Weight |
2021-06-08 | Hochstufung | Citigroup | Sell → Neutral |
2021-06-08 | Bestätigt | H.C. Wainwright | Buy |
2021-06-08 | Bestätigt | Jefferies | Buy |
2021-06-08 | Bestätigt | Morgan Stanley | Overweight |
2021-06-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
2021-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
2021-06-08 | Bestätigt | Stifel | Buy |
2021-06-08 | Hochstufung | William Blair | Mkt Perform → Outperform |
2021-06-07 | Hochstufung | BofA Securities | Underperform → Neutral |
2021-06-07 | Hochstufung | Cowen | Market Perform → Outperform |
2021-06-07 | Hochstufung | Raymond James | Underperform → Mkt Perform |
2021-02-05 | Herabstufung | DZ Bank | Buy → Hold |
2021-01-29 | Hochstufung | Stifel | Hold → Buy |
2020-11-10 | Hochstufung | DZ Bank | Hold → Buy |
2020-11-09 | Herabstufung | Atlantic Equities | Neutral → Underweight |
2020-11-09 | Herabstufung | BofA Securities | Neutral → Underperform |
2020-11-09 | Herabstufung | Cowen | Outperform → Market Perform |
2020-11-09 | Bestätigt | H.C. Wainwright | Buy |
2020-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
2020-11-04 | Hochstufung | Jefferies | Hold → Buy |
2020-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-10-28 | Eingeleitet | UBS | Neutral |
2020-07-27 | Hochstufung | Morgan Stanley | Underweight → Overweight |
2020-06-22 | Herabstufung | Barclays | Overweight → Equal Weight |
2020-06-22 | Bestätigt | RBC Capital Mkts | Sector Perform |
2020-06-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2020-04-23 | Herabstufung | Citigroup | Neutral → Sell |
2020-04-23 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
2020-02-27 | Eingeleitet | Barclays | Overweight |
2020-01-27 | Hochstufung | Canaccord Genuity | Hold → Buy |
2019-12-13 | Hochstufung | Credit Suisse | Underperform → Neutral |
2019-12-02 | Herabstufung | Robert W. Baird | Neutral → Underperform |
Alle ansehen
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Biogen (BIIB) Highlights Promising Results of Dapirolizumab Pego - GuruFocus
Biogen to present dapirolizumab pegol SLE study results at ACR - Investing.com
Biogen (BIIB) Valuation in Focus After New Dravet Syndrome Data Shows Extended Clinical Benefit - simplywall.st
Citizens & Northern Corp Has $883,000 Stake in Biogen Inc. $BIIB - MarketBeat
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors - GlobeNewswire Inc.
Biogen Announces Phase 3 Study Results of Dapirolizumab Pegol in Systemic Lupus Erythematosus to Be Presented at ACR Convergence 2025 - Quiver Quantitative
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 - Biogen
How Biogen Inc. (IDP) stock behaves in tightening cyclesWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - newser.com
Mutual Advisors LLC Acquires New Shares in Biogen Inc. $BIIB - MarketBeat
Using data filters to optimize entry into Biogen Inc.2025 Market Trends & Community Consensus Stock Picks - newser.com
Will Biogen Inc. (IDP) stock benefit from commodity supercycle2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com
Historical volatility pattern of Biogen Inc. visualizedVolume Spike & AI Driven Stock Reports - newser.com
Institutional scanner results for Biogen Inc.July 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
Sector ETF performance correlation with Biogen Inc.July 2025 Macro Moves & Real-Time Volume Triggers - newser.com
Can Biogen Inc. stock double in next 5 yearsQuarterly Profit Report & Free Safe Capital Growth Stock Tips - newser.com
Biogen Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
20,500 Shares in Biogen Inc. $BIIB Acquired by Privium Fund Management B.V. - MarketBeat
Is it time to cut losses on Biogen Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Is Biogen Inc. stock a top momentum playPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com
Volatility clustering patterns for Biogen Inc.July 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
How to escape a deep drawdown in Biogen Inc.Market Sentiment Summary & Safe Entry Zone Tips - newser.com
Lobbying Update: $990,000 of BIOGEN lobbying was just disclosed - Quiver Quantitative
Is Biogen Inc. (IDP) stock a buy on weakness2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Key metrics from Biogen Inc.’s quarterly dataBreakout Watch & Weekly High Return Stock Forecasts - newser.com
Biogen Inc.’s volatility index tracking explainedJobs Report & Long Hold Capital Preservation Plans - newser.com
J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround - AOL.com
Is a relief rally coming for Biogen Inc. holdersTrade Volume Summary & AI Powered Buy and Sell Recommendations - newser.com
Biogen (BIIB) breakout and retrace signals buying opportunity - FXStreet
Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a safe buy before earningsJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
Is Biogen Inc. forming a reversal patternJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
New York State Teachers Retirement System Has $13.90 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB - MarketBeat
Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story? - simplywall.st
Is Biogen Inc. stock a buy before product launchesQuarterly Growth Report & Smart Swing Trading Alerts - nchmf.gov.vn
Gains Report: Is Biogen Inc. stock a buy before product launchesProduct Launch & Safe Entry Momentum Tips - nchmf.gov.vn
Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB - MarketBeat
TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB - MarketBeat
Yousif Capital Management LLC Has $2.48 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a defensive play in 20252025 Historical Comparison & AI Forecast Swing Trade Picks - nchmf.gov.vn
Gains Recap: Is Biogen Inc. stock a buy before product launchesTrade Performance Summary & Short-Term Trading Opportunity Alerts - nchmf.gov.vn
How Biogen Inc. stock compares to market leadersTreasury Yields & Reliable Trade Execution Plans - nchmf.gov.vn
Using portfolio simulators with Biogen Inc. includedQuarterly Trade Review & Stock Market Timing Techniques - newser.com
Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str - GuruFocus
Wedbush Has Optimistic Outlook of Biogen Q1 Earnings - MarketBeat
Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB - MarketBeat
Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB - MarketBeat
Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB - MarketBeat
Biogen Inc. Stock Falls by 3.65% - Idéal Investisseur
Is Biogen Now an Opportunity After Recent 25% Share Price Decline? - simplywall.st
Finanzdaten der Biogen Inc-Aktie (BIIB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):